Among these new candidates, Annexin A4 (ANXA4) had been reported to play a role in drug resistance, with its expression increased in clones resistant to paclitaxel [36], a drug commonly used in the treatment of cancer patients. This evidence concerns the gene ANXA4 and cancer.